Patients with known hypersensitivity to Stugeron.
Use in pregnancy: Although cinnarizine gives no evidence of embryotoxic or teratogenic properties in animals, potential hazards of prescribing drugs during pregnancy should always be weighed against expected therapeutic benefits.